“Response of oral Melphalan, Prednisone and Thalidomide (MPT) on symptomatic multiple myeloma patients who are non-transplant candidates”, J Dhaka Med Coll, vol. 25, no. 1, pp. 61–66, Sep. 2017, doi: 10.3329/jdmc.v25i1.33957.